PhaseBio Pharmaceuticals, Inc. (PHASQ) and trades at $0.00. The 52-week range is 1.0E-6-0.0399.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $0.00, annual revenue of $10.83K.
The stock has a beta of 2.01, operates in the Healthcare sector.
